# Efficacy of Tranexamic Acid in Preventing Post Operative Blood Loss in Bone Sarcoma Patient

> **NCT05427513** · EARLY_PHASE1 · UNKNOWN · sponsor: **Shaukat Khanum Memorial Cancer Hospital & Research Centre** · enrollment: 42 (estimated)

## Conditions studied

- Blood Loss, Surgical

## Interventions

- **DRUG:** Tranexamic acid injection
- **OTHER:** normal saline

## Key facts

- **NCT ID:** NCT05427513
- **Lead sponsor:** Shaukat Khanum Memorial Cancer Hospital & Research Centre
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-06
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-02-28
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2023-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05427513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05427513, "Efficacy of Tranexamic Acid in Preventing Post Operative Blood Loss in Bone Sarcoma Patient". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05427513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*